Autres langues Bruker Corporation

Actions

BRKR

US1167941087

Temps réel estimé Cboe BZX Autres places de cotation 19:10:23 03/05/2024			Varia. 5j.	Varia. 1 janv.
70,08 ^USD	-0,01 %		-13,09 %	-4,23 %

02/05	Les actions de Bruker chutent après que les revenus du premier trimestre aient été inférieurs aux prévisions du consensus ; la société revoit à la hausse ses prévisions pour l'ensemble de l'année.	MT
02/05	Transcript : Bruker Corporation, Q1 2024 Earnings Call, May 02, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Bruker Shares Fall After Q1 Revenue Misses Consensus Views; Lifts Full-Year Guidance	02/05
Bruker: Q1 Earnings Snapshot	02/05
Earnings Flash (BRKR) BRUKER CORPORATION Posts Q1 Revenue $721.7M, vs. Street Est of $729M	02/05
Earnings Flash (BRKR) BRUKER CORPORATION Reports Q1 EPS $0.53, vs. Street Est of $0.46	02/05
Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech	02/05
Bruker Reports First Quarter 2024 Financial Results	02/05
Bruker Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Bruker Corporation Revises Earnings Guidance for the Year 2024	02/05
Bruker Corporation completed the acquisition of ELITech Group SAS from Tecfin S.À R.L.	30/04
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference	26/04
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference	26/04
Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast	25/04
Bruker Agrees Signs Asset Purchase Deal With NanoString Technologies	22/04
Bruker to Acquire the NanoString Business in an Asset Deal	22/04
Bruker Corporation entered into an agreement to acquire Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $390 million.	17/04
Bruker : Showcases High-Performance Solutions at Analytica 2024 for Research and Analysis in Applied, Industrial and Biopharma Laboratories	09/04
Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates	08/04
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies	08/04
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies	08/04
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research	05/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Bruker Corporation

Actions

BRKR

US1167941087

Autres langues

Filtres